BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim BW, Ryu J, Jeong YE, Kim J, Martin LJ. Human Motor Neurons With SOD1-G93A Mutation Generated From CRISPR/Cas9 Gene-Edited iPSCs Develop Pathological Features of Amyotrophic Lateral Sclerosis. Front Cell Neurosci 2020;14:604171. [PMID: 33328898 DOI: 10.3389/fncel.2020.604171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sen T, Thummer RP. CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics. Neurotox Res 2022. [PMID: 36044181 DOI: 10.1007/s12640-022-00564-w] [Reference Citation Analysis]
2 De Plano LM, Calabrese G, Conoci S, Guglielmino SPP, Oddo S, Caccamo A. Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders. Int J Mol Sci 2022;23:8714. [PMID: 35955847 DOI: 10.3390/ijms23158714] [Reference Citation Analysis]
3 Datta A, Sarmah D, Kaur H, Chaudhary A, Vadak N, Borah A, Shah S, Wang X, Bhattacharya P. Advancement in CRISPR/Cas9 Technology to Better Understand and Treat Neurological Disorders. Cell Mol Neurobiol 2022. [PMID: 35751791 DOI: 10.1007/s10571-022-01242-3] [Reference Citation Analysis]
4 Gunes ZI, Kan VWY, Jiang S, Logunov E, Ye X, Liebscher S. Cortical Hyperexcitability in the Driver’s Seat in ALS. CTN 2022;6:5. [DOI: 10.3390/ctn6010005] [Reference Citation Analysis]
5 Giacomelli E, Vahsen BF, Calder EL, Xu Y, Scaber J, Gray E, Dafinca R, Talbot K, Studer L. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell 2022;29:11-35. [PMID: 34995492 DOI: 10.1016/j.stem.2021.12.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
6 Trudler D, Ghatak S, Lipton SA. Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases. Int J Mol Sci 2021;22:8196. [PMID: 34360966 DOI: 10.3390/ijms22158196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhu X, Zhang Y, Yang X, Hao C, Duan H. Gene Therapy for Neurodegenerative Disease: Clinical Potential and Directions. Front Mol Neurosci 2021;14:618171. [PMID: 34194298 DOI: 10.3389/fnmol.2021.618171] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Karpe Y, Chen Z, Li XJ. Stem Cell Models and Gene Targeting for Human Motor Neuron Diseases. Pharmaceuticals (Basel) 2021;14:565. [PMID: 34204831 DOI: 10.3390/ph14060565] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Lin X, Tang J, Lou YR. Human Pluripotent Stem-Cell-Derived Models as a Missing Link in Drug Discovery and Development. Pharmaceuticals (Basel) 2021;14:525. [PMID: 34070895 DOI: 10.3390/ph14060525] [Cited by in F6Publishing: 5] [Reference Citation Analysis]